Determine in vitro susceptibility to antimicrobial agents for gram-positive rod bacterial organisms.
New York DOH Approval Status
Actively growing isolate in pure culture.
Transport sealed container with pure culture on agar slant or in bacterial transport media. Place each specimen in an individually sealed bag.
Room temperature. If culture is suspected of being a microorganism identified on the IATA list as an infectious substance affecting humans, submit specimen according to Infectious Substance, Category A, shipping guidelines.
Mixed cultures or non-viable organisms.
Isolate identification and specimen source required.
Ambient: 1 week; Refrigerated: Unacceptable; Frozen: Unacceptable
Susceptible, intermediate, or resistant
Susceptibility testing is performed by CLSI-approved broth microdilution method using custom-made MIC panels.
Laboratory Developed Test (LDT)
The following agents will be tested: cefriaxone, clindamycin, daptomycin, doxycycline, erythromycin, gentamicin, levofloxacin, meropenem, penicillin, rifampin, trimethoprim-sulfamethoxazole, and vancomycin. Selective reporting by organism and source.
An additional processing fee will be billed for all organisms not submitted in pure culture, as indicated in the specimen requirements.
If species identification is not provided, identification will be performed at ARUP. Additional charges apply.
|Component Test Code*||Component Chart Name||LOINC|
|0060346||Susceptibility, Gram Positive Rod||29576-6|
- Corynebacterium species
- Erysipelothrix; Bacillus